Showing results (711-720 of 1,033) with videos related to
Sort By:
Pageof 104
The Lancet. Respiratory Medicine|April 22, 2021
Extracorporeal membrane oxygenation network organisation and clinical outcomes during the COVID-19 pandemic in Greater Paris, France: a multicentre cohort studyGuillaume Lebreton, Matthieu Schmidt, Maharajah Ponnaiah, et al.The Lancet. Respiratory Medicine|April 18, 2021
SARS-CoV-2 seropositivity and subsequent infection risk in healthy young adults: a prospective cohort studyAndrew G Letizia, Yongchao Ge, Sindhu Vangeti, et al.The Lancet. Respiratory Medicine|May 8, 2023
Sintilimab plus chemotherapy for patients with EGFR-mutated non-squamous non-small-cell lung cancer with disease progression after EGFR tyrosine-kinase inhibitor therapy (ORIENT-31): second interim analysis from a double-blind, randomised, placebo-controlled, phase 3 trialShun Lu, Lin Wu, Hong Jian, et al.The Lancet. Respiratory Medicine|March 2, 2015
Safety, immunogenicity, and efficacy of the candidate tuberculosis vaccine MVA85A in healthy adults infected with HIV-1: a randomised, placebo-controlled, phase 2 trialBirahim Pierre Ndiaye, Friedrich Thienemann, Martin Ota, et al.The Lancet. Respiratory Medicine|March 31, 2015
Efficacy and safety of an intensified schedule of tremelimumab for chemotherapy-resistant malignant mesothelioma: an open-label, single-arm, phase 2 studyLuana Calabrò, Aldo Morra, Ester Fonsatti, et al.The Lancet. Respiratory Medicine|July 28, 2020
Point-of-care serological assays for delayed SARS-CoV-2 case identification among health-care workers in the UK: a prospective multicentre cohort studyScott J C Pallett, Michael Rayment, Aatish Patel, et al.The Lancet. Respiratory Medicine|July 13, 2020
Once-daily, single-inhaler mometasone-indacaterol-glycopyrronium versus mometasone-indacaterol or twice-daily fluticasone-salmeterol in patients with inadequately controlled asthma (IRIDIUM): a randomised, double-blind, controlled phase 3 studyHuib A M Kerstjens, Jorge Maspero, Kenneth R Chapman, et al.The Lancet. Respiratory Medicine|July 11, 2020
Circulating tumour cells as a potential biomarker for lung cancer screening: a prospective cohort studyCharles-Hugo Marquette, Jacques Boutros, Jonathan Benzaquen, et al.The Lancet. Respiratory Medicine|January 28, 2014
New treatments for severe treatment-resistant asthma: targeting the right patientKian Fan ChungThe Lancet. Respiratory Medicine|January 28, 2014
Severity assessment scores to guide empirical use of antibiotics in community acquired pneumoniaAran Singanayagam, James D ChalmersPageof 104